ACS Applied Materials & Interfaces · 2018 · 60 citations · 28 references
PharmacyImmunologyPharmaceuticsDrug DeliveryImmunizationNanoparticle Drug DeliveryDrug EncapsulationNanoparticle Delivery SystemsNanoparticle FormulationsVaccine DeliveryVaccine Delivery SystemsVaccine PlatformsAdjuvant DeliveryAntigen Presenting CellsHydrogel Delivery SystemsNanoparticle Vaccine PlatformsNanoparticlesTargeted DeliveryTargeted Delivery SystemsVaccine Delivery Formulations
The combination of an antigen and adjuvant has synergistic effects on an immune response. Coadministration of an antigen and a granulocyte-macrophage colony-stimulating factor (GM-CSF) hydrogel delivery system will afford a novel strategy for enhancement of an immune response because of the dual role of the hydrogel as a vaccine carrier with a sustained release and a platform for recruiting dendritic cells (DCs). Herein, an injectable poly(caprolactone)–poly(ethylene glycol)–poly(caprolactone) thermosensitive hydrogel coencapsulating GM-CSF and ovalbumin nanoparticles was developed to enhance antigen uptake efficiency. The GM-CSF released from the hydrogel ensured accumulation of DCs; this effect improved the antigen uptake efficiency with the targeted delivery to antigen-presenting cells. Furthermore, the dual delivery system induced a stronger immune effect, including higher CD8+ T proportion, interferon γ secretion, and a greater cytotoxic T lymphocyte response, which may benefit from the recruitment of DCs, increasing antigen residence time, and the controllable antigen release owing to the combined effect of the hydrogel and nanoparticles. Meanwhile, the real-time antigen delivery process in vivo was revealed by a noninvasive fluorescence imaging method. All of the results indicated that the visible dual delivery system may have a greater potential for the efficient and trackable vaccine delivery.
28
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Daniela Schmid, Chun Gwon Park, Christina Hartl et al. · Nature Communications · 2017 · 441 citations · Full text
Medicine, Immunology, Oncology +17
Zhenghong Xu, Srinivas Ramishetti, Yu-Cheng Tseng et al. · Journal of Controlled Release · 2013 · 217 citations
Medicine, Immunology, Oncology +17